Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT00989963 · COMPLETED
Trial details
- NCT number
- NCT00989963
- Sponsor
- Lung Biotechnology PBC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-09-13
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.